• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在中低收入国家扩大慢性病预防干预措施。

Scaling up chronic disease prevention interventions in lower- and middle-income countries.

机构信息

Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.

出版信息

Annu Rev Public Health. 2013;34:317-35. doi: 10.1146/annurev-publhealth-031912-114402. Epub 2013 Jan 7.

DOI:10.1146/annurev-publhealth-031912-114402
PMID:23297660
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3686269/
Abstract

Chronic diseases are increasingly becoming a health burden in lower- and middle-income countries, putting pressure on public health efforts to scale up interventions. This article reviews current efforts in interventions on a population and individual level. Population-level interventions include ongoing efforts to reduce smoking rates, reduce intake of salt and trans-fatty acids, and increase physical activity in increasingly sedentary populations. Individual-level interventions include control and treatment of risk factors for chronic diseases and secondary prevention. This review also discusses the barriers in interventions, particularly those specific to low- and middle-income countries. Continued discussion of proven cost-effective interventions for chronic diseases in the developing world will be useful for improving public health policy.

摘要

慢性病在中低收入国家日益成为健康负担,给扩大干预措施的公共卫生工作带来压力。本文综述了在人群和个体层面干预的现状。人群层面的干预措施包括正在努力降低吸烟率、减少盐和反式脂肪酸的摄入,以及增加久坐人群的体力活动。个体层面的干预措施包括控制和治疗慢性病的危险因素和二级预防。本文还讨论了干预措施中存在的障碍,特别是针对中低收入国家的障碍。继续讨论发展中国家慢性病经证实具有成本效益的干预措施,将有助于改善公共卫生政策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5244/3686269/b4397f937879/nihms-484620-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5244/3686269/feafe0fbfe41/nihms-484620-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5244/3686269/88ddcbc5bc95/nihms-484620-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5244/3686269/b4397f937879/nihms-484620-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5244/3686269/feafe0fbfe41/nihms-484620-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5244/3686269/88ddcbc5bc95/nihms-484620-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5244/3686269/b4397f937879/nihms-484620-f0003.jpg

相似文献

1
Scaling up chronic disease prevention interventions in lower- and middle-income countries.在中低收入国家扩大慢性病预防干预措施。
Annu Rev Public Health. 2013;34:317-35. doi: 10.1146/annurev-publhealth-031912-114402. Epub 2013 Jan 7.
2
Improving the prevention and management of chronic disease in low-income and middle-income countries: a priority for primary health care.改善低收入和中等收入国家慢性病的预防与管理:初级卫生保健的一项优先任务。
Lancet. 2008 Sep 13;372(9642):940-9. doi: 10.1016/S0140-6736(08)61404-X.
3
Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use.慢性病预防:减少盐摄入和控制烟草使用策略的健康影响及经济成本
Lancet. 2007 Dec 15;370(9604):2044-53. doi: 10.1016/S0140-6736(07)61698-5. Epub 2007 Dec 11.
4
Prevention of chronic diseases: a call to action.慢性病的预防:行动呼吁。
Lancet. 2007 Dec 22;370(9605):2152-7. doi: 10.1016/S0140-6736(07)61700-0. Epub 2007 Dec 11.
5
Scaling up interventions for chronic disease prevention: the evidence.扩大慢性病预防干预措施:证据
Lancet. 2007 Dec 8;370(9603):1939-46. doi: 10.1016/S0140-6736(07)61697-3.
6
Tuberculosis结核病
7
Cost-effectiveness of reducing salt intake in the Pacific Islands: protocol for a before and after intervention study.太平洋岛屿减少盐摄入量的成本效益:一项干预前后研究的方案
BMC Public Health. 2014 Feb 4;14:107. doi: 10.1186/1471-2458-14-107.
8
The Community Health Assessment Program in the Philippines (CHAP-P) diabetes health promotion program for low- to middle-income countries: study protocol for a cluster randomized controlled trial.菲律宾社区卫生评估计划(CHAP-P)糖尿病健康促进计划在中低收入国家的应用:一项群组随机对照试验的研究方案。
BMC Public Health. 2019 Jun 3;19(1):682. doi: 10.1186/s12889-019-6974-z.
9
Practical dietary interventions to prevent cardiovascular disease suitable for implementation in primary care: an ADAPTE-guided systematic review of international clinical guidelines.适合在初级保健中实施的预防心血管疾病的实用饮食干预措施:一项基于 ADAPTE 指南的国际临床指南系统评价。
Int J Behav Nutr Phys Act. 2023 Jul 28;20(1):93. doi: 10.1186/s12966-023-01463-9.
10
Multiple risk factor interventions for primary prevention of cardiovascular disease in low- and middle-income countries.中低收入国家心血管疾病一级预防的多重危险因素干预措施
Cochrane Database Syst Rev. 2015 Aug 4;2015(8):CD011163. doi: 10.1002/14651858.CD011163.pub2.

引用本文的文献

1
Parents' experience in pediatric Tuina treatment program for congenital muscular torticollis in infants and children: qualitative findings from individual interviews.家长对婴幼儿先天性肌性斜颈小儿推拿治疗方案的体验:个体访谈的质性研究结果
BMC Complement Med Ther. 2025 Jul 12;25(1):260. doi: 10.1186/s12906-025-05000-y.
2
Outpatient Cardiovascular Rehabilitation Registry in Iran: The First Rehabilitation Registry Experience at EMR.伊朗门诊心血管康复登记系统:电子病历系统中的首次康复登记经验。
ARYA Atheroscler. 2023 Sep-Oct;19(5):9-17. doi: 10.48305/arya.2023.41410.2874.
3
The effect of cigarette smoking on the oral microbiota in a South African population using subgingival plaque samples.

本文引用的文献

1
Use of a Multidrug Pill In Reducing cardiovascular Events (UMPIRE): rationale and design of a randomised controlled trial of a cardiovascular preventive polypill-based strategy in India and Europe.多药复方药丸用于降低心血管事件(UMPIRE):印度和欧洲基于心血管预防多药丸策略的随机对照试验的原理与设计
Eur J Prev Cardiol. 2014 Feb;21(2):252-61. doi: 10.1177/2047487312463278. Epub 2012 Oct 4.
2
Trends in compulsory licensing of pharmaceuticals since the Doha Declaration: a database analysis.《多哈宣言》之后药品强制许可的趋势:数据库分析。
PLoS Med. 2012 Jan;9(1):e1001154. doi: 10.1371/journal.pmed.1001154. Epub 2012 Jan 10.
3
使用龈下菌斑样本研究吸烟对南非人群口腔微生物群的影响。
Heliyon. 2024 May 21;10(10):e31559. doi: 10.1016/j.heliyon.2024.e31559. eCollection 2024 May 30.
4
Tackling the non-communicable disease epidemic: a framework for policy action in low- and middle-income countries.应对非传染性疾病流行:中低收入国家政策行动框架。
Pan Afr Med J. 2024 Feb 26;47:82. doi: 10.11604/pamj.2024.47.82.41089. eCollection 2024.
5
Causal Paradigm Between Common Comorbidities of Cardiovascular and Metabolism-Related Diseases in Elderly: Evidence from Cross-Sectional and Mendelian Randomization Studies.老年人心血管疾病与代谢相关疾病常见合并症之间的因果范式:来自横断面研究和孟德尔随机化研究的证据
Diabetes Metab Syndr Obes. 2023 Sep 22;16:2953-2966. doi: 10.2147/DMSO.S427103. eCollection 2023.
6
Exploring health promotion efforts for non-communicable disease prevention and control in Ghana.探索加纳非传染性疾病预防与控制的健康促进工作。
PLOS Glob Public Health. 2023 Sep 25;3(9):e0002408. doi: 10.1371/journal.pgph.0002408. eCollection 2023.
7
Burden of Stroke and Population-Attributable Fractions of Risk Factors in Latin America and the Caribbean.拉丁美洲和加勒比地区的卒中负担及危险因素的人群归因分数。
J Am Heart Assoc. 2022 Nov;11(21):e027044. doi: 10.1161/JAHA.122.027044. Epub 2022 Oct 26.
8
Barriers and Facilitators in Access to Diabetes, Hypertension, and Dyslipidemia Medicines: A Scoping Review.糖尿病、高血压和血脂异常药物获取的障碍与促进因素:一项范围综述
Public Health Rev. 2022 Sep 2;43:1604796. doi: 10.3389/phrs.2022.1604796. eCollection 2022.
9
Prevalence of short and long sleep duration: Ravansar NonCommunicable Disease (RaNCD) cohort study.短睡眠和长睡眠持续时间的流行率:拉万萨尔非传染性疾病(RaNCD)队列研究。
BMC Public Health. 2022 Aug 29;22(1):1631. doi: 10.1186/s12889-022-14061-4.
10
Global Awareness of Myocardial Infarction Symptoms in General Population: a Systematic Review and Meta-Analysis.普通人群对心肌梗死症状的全球认知:一项系统评价和荟萃分析。
Korean Circ J. 2021 Dec;51(12):983-996. doi: 10.4070/kcj.2021.0100. Epub 2021 Sep 1.
Economic evaluation of pharmaco- and behavioral therapies for smoking cessation: a critical and systematic review of empirical research.
药物和行为疗法戒烟的经济学评价:对实证研究的批判性和系统性回顾。
Annu Rev Public Health. 2012 Apr;33:279-305. doi: 10.1146/annurev-publhealth-031811-124553. Epub 2012 Jan 3.
4
Preventability of cancer: the relative contributions of biologic and social and physical environmental determinants of cancer mortality.癌症的可预防性:生物和社会及物理环境决定因素对癌症死亡率的相对贡献。
Annu Rev Public Health. 2012 Apr;33:137-56. doi: 10.1146/annurev-publhealth-031811-124627. Epub 2012 Jan 3.
5
Urinary sodium and potassium excretion and risk of cardiovascular events.尿钠和尿钾排泄与心血管事件风险。
JAMA. 2011 Nov 23;306(20):2229-38. doi: 10.1001/jama.2011.1729.
6
Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey.高收入、中等收入和低收入国家(PURE 研究)社区中用于心血管疾病二级预防的药物:一项前瞻性流行病学调查。
Lancet. 2011 Oct 1;378(9798):1231-43. doi: 10.1016/S0140-6736(11)61215-4. Epub 2011 Aug 26.
7
Differences in the availability of medicines for chronic and acute conditions in the public and private sectors of developing countries.发展中国家公共部门和私营部门可获得的慢性和急性疾病药物存在差异。
Bull World Health Organ. 2011 Jun 1;89(6):412-21. doi: 10.2471/BLT.10.084327. Epub 2011 Mar 14.
8
A comparative assessment of non-laboratory-based versus commonly used laboratory-based cardiovascular disease risk scores in the NHANES III population.NHANES III 人群中非基于实验室的与常用基于实验室的心血管疾病风险评分的比较评估。
PLoS One. 2011;6(5):e20416. doi: 10.1371/journal.pone.0020416. Epub 2011 May 31.
9
Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion.与尿钠排泄量有关的致死和非致死结局、高血压发生率和血压变化。
JAMA. 2011 May 4;305(17):1777-85. doi: 10.1001/jama.2011.574.
10
Proportion of the decline in cardiovascular mortality disease due to prevention versus treatment: public health versus clinical care.心血管疾病死亡率下降中源于预防的部分与源于治疗的部分之比:公共卫生与临床护理。
Annu Rev Public Health. 2011;32:5-22. doi: 10.1146/annurev-publhealth-031210-101211.